Testing of drug combinations for mycobacterium tuberculosis (MTB) in mice
Ended Awarded Last action
- Contract number
- 75N93022F00001
- Awardee
-
Colorado State University UEI LT9CXX8L19G1 Part of Colorado State University System
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,457,348
Award facts
- Opportunity
-
- 75N93022F00001 Solicitation number
- Contract value 100% obligated
- $1,457,348.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Fort Collins, CO 80523, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $207,029 | |
| Other Administrative Action | $0 | |
| Original award | $1,250,319 |
About this award
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Colorado State University to conduct testing of drug combinations for Mycobacterium tuberculosis (MTB) in mice. The $1,457,348.00 contract is a delivery order under NIAID's Preclinical Services for HIV Therapeutics master indefinite-delivery, indefinite-quantity (IDIQ) contract.
The contract does not have a set-aside designation. Colorado State University is the prime contractor, and the University of Colorado-Denver is a subcontractor. The purpose is to test standard MTB combination drugs in a small animal model. This work supports NIAID's broader mission in preclinical services for the development of HIV therapeutics.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to Colorado State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2022.
How much is contract 75N93022F00001 worth?
The government has obligated $1,457,348 on 75N93022F00001.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under 75N93021D00014, an indefinite delivery contract, on Preclinical Services for HIV Therapeutics.
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award